Halozyme Therapeutics shares owned by Driehaus Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Driehaus Capital Management
from 13F filings
Historical chart of Driehaus Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Driehaus Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Driehaus Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $20M | 521k | 38.20 |
| 2023-06-30 | $19M | 519k | 36.07 |
| 2023-03-31 | $19M | 501k | 38.19 |
| 2022-12-31 | $76M | 1.3M | 56.90 |
| 2022-09-30 | $53M | 1.3M | 39.54 |
| 2022-06-30 | $56M | 1.3M | 44.00 |
| 2022-03-31 | $34M | 844k | 39.88 |
| 2021-12-31 | $24M | 585k | 40.21 |
| 2021-09-30 | $34M | 831k | 40.68 |
| 2021-06-30 | $26M | 567k | 45.41 |
| 2021-03-31 | $19M | 455k | 41.69 |
| 2020-12-31 | $12M | 285k | 42.71 |
| 2020-09-30 | $6.9M | 264k | 26.28 |
| 2020-06-30 | $6.6M | 247k | 26.81 |
| 2020-03-31 | $4.3M | 240k | 17.99 |
More positions owned by Driehaus Capital Management
View all positions for Driehaus Capital Management